Published in Scand J Gastroenterol on January 01, 1975
What is happening to peptic ulcer? Br Med J (Clin Res Ed) (1982) 1.70
A reappraisal of time trends in ulcer disease: factors related to changes in ulcer hospitalization and mortality rates. Am J Public Health (1983) 1.56
Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. Br Med J (1977) 1.20
Increased susceptibility of rat gastric mucosa to ulcerogenic stimulation with aging. Role of capsaicin-sensitive sensory neurons. Dig Dis Sci (1996) 1.16
Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study. Gut (1995) 1.12
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci (1997) 1.03
Incidence of peptic ulcer disease in Gothenburg, 1985. BMJ (1989) 1.01
The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health (1985) 0.99
Time trends in peptic ulcer surgery, 1956 to 1986. A nation-wide survey in Sweden. Ann Surg (1989) 0.95
Effects of aging on duodenal bicarbonate secretion. Ann Surg (1990) 0.86
Changing incidence of peptic ulcer--facts or artefacts? A cohort study from Tromsø. J Epidemiol Community Health (1992) 0.86
Changing demographics of peptic ulcer disease. Dig Dis Sci (1985) 0.85
A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Emerg Infect Dis (2000) 0.78
Gastric Ulcers in Middle-Aged Rats: The Healing Effect of Essential Oil from Citrus aurantium L. (Rutaceae). Evid Based Complement Alternat Med (2012) 0.77
Why not have definitive trials of gastrointestinal safety for non-steroidal anti-inflammatory drugs? Discussion paper. J R Soc Med (1988) 0.77
Gastroscopic evaluation of antiinflammatory agents. Br Med J (1980) 0.75
Benign gastric ulceration in a health district: incidence and presentation. Postgrad Med J (1985) 0.75
Trends in peptic ulcer mortality in Italy, 1955-1985. J Epidemiol Community Health (1992) 0.75
Differences in gastroprotective processes in 6- to 8- and 14- to 16-week-old rats. Dig Dis Sci (2002) 0.75
The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Scand J Gastroenterol (1973) 1.82
The prognosis of ulcerative colitis. Scand J Gastroenterol (1974) 1.74
Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut (2003) 1.46
[Prevention of duodenal ulcer recurrence with penicillin]. Ugeskr Laeger (1994) 1.39
An epidemiological study of regional enteritis and acute ileitis in Copenhagen County. Scand J Gastroenterol (1973) 1.38
The incidence of duodenal ulcer in Copenhagen county. Scand J Gastroenterol (1975) 1.38
Survival in peptic ulcer. Gastroenterology (1978) 1.36
An epidemiological study of ulcerative colitis in Copenhagen County. Scand J Gastroenterol (1968) 1.32
Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut (1997) 1.24
Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother (1997) 1.21
Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. Br Med J (1977) 1.20
Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology (1998) 1.16
Causes of death in duodenal and gastric ulcer. Gastroenterology (1977) 1.14
Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology (2000) 1.10
Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand (1985) 1.02
Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health (2000) 1.02
Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health (2000) 1.00
A diagnostic study of patients with upper abdominal pain. Scand J Gastroenterol (1975) 1.00
Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol (1984) 0.98
Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population. Am J Epidemiol (1996) 0.97
The incidence of gastric ulcer and duodenal ulcer in north Norway. A prospective epidemiological study. Scand J Gastroenterol (1985) 0.96
Socioeconomic factors in Helicobacter pylori infection among Danish adults. Am J Public Health (1996) 0.95
The incidence of peptic ulcer disease related to occupation in the northern part of Norway. A prospective epidemiological and radiological study. Scand J Gastroenterol (1985) 0.95
[In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana]. Bull Soc Pathol Exot Filiales (1988) 0.94
The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial. Scand J Gastroenterol (1978) 0.91
Smoking, alcohol, coffee, and familial factors: any associations with peptic ulcer disease? A clinically and radiologically prospective study. Scand J Gastroenterol (1985) 0.91
Haemodynamic response to exercise in patients with alcoholic liver cirrhosis. Clin Physiol (1987) 0.90
Time trends for peptic ulcer disease in Denmark, 1981-1993. Analysis of hospitalization register and mortality data. Scand J Gastroenterol (1998) 0.90
Changes in the pattern of peptic ulcer disease in the northern part of Norway between 1946 and 1981. Scand J Gastroenterol (1982) 0.87
Double-blind randomised clinical trial of a pepsin-inhibitory pentapeptide (pepstatin) in the treatment of duodenal ulcer. Gut (1979) 0.87
Nosography of X-ray negative dyspepsia. Scand J Gastroenterol (1976) 0.86
Changing demographics of peptic ulcer disease. Dig Dis Sci (1985) 0.85
Does Helicobacter pylori infection explain all socio-economic differences in peptic ulcer incidence? Genetic and psychosocial markers for incident peptic ulcer disease in a large cohort of Danish adults. Scand J Gastroenterol (2004) 0.83
Left ventricular performance in alcoholic patients without chronic liver disease. Br Heart J (1987) 0.83
Spontaneous healing of duodenal ulcers. Scand J Gastroenterol (1984) 0.82
Epidemiological aspects of peptic ulcer disease on the Faroe Islands. An interim report. Scand J Gastroenterol (1985) 0.81
Prognostic value of the augmented histamine test in ulcer disease and x-ray negative dyspepsia. Scand J Gastroenterol (1971) 0.81
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol (2000) 0.80
Dyspepsia: Future research--methodological aspects. Scand J Gastroenterol Suppl (1987) 0.79
Ulcerative colitis in children. Treatment, course, and prognosis. Scand J Gastroenterol (1973) 0.79
[Basis for ulcus therapy in general practice]. Ugeskr Laeger (1988) 0.79
Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long-term comparative study. Aliment Pharmacol Ther (1998) 0.78
Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study. Scand J Gastroenterol (1993) 0.77
[A socioeconomic study of patients with ulcerative colitis]. Ugeskr Laeger (1967) 0.77
[Peptic ulcer in Denmark, 1981-1993. Analysis of data from national patient registries]. Ugeskr Laeger (1999) 0.77
[Ulcer relation to social and occupational factors. An epidemiological study]. Ugeskr Laeger (1979) 0.77
Gastric and duodenal ulcers in the same patient. Scand J Gastroenterol (1975) 0.77
An epidemiological model of ulcerative colitis. Scand J Gastroenterol (1968) 0.77
The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survival. J Hepatol (1994) 0.76
The incidence in Copenhagen County of gastric and duodenal ulcers in the same patient. Scand J Gastroenterol (1975) 0.76
Gastric ulcer therapy with a pepsin-inactivating peptide, pepstatin: a double-blind randomized clinical trial. Scand J Gastroenterol (1979) 0.76
Identifying responders to acid suppression in dyspepsia using a random starting day trial. Aliment Pharmacol Ther (2000) 0.76
Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily. Scand J Gastroenterol (1985) 0.76
The incidence and result of radiological examination of the stomach using a barium meal. Scand J Gastroenterol (1976) 0.76
Acyclovir in the prevention of duodenal ulcer recurrence. Gut (1990) 0.75
Outcome of non-ulcer disease. Scand J Gastroenterol Suppl (1982) 0.75
The personality pattern of duodenal ulcer patients in relation to spontaneous ulcer healing and relapse. J Intern Med (1989) 0.75
[Prognosis of peptic ulcer. Mortality evaluated in relation to the diagnostic situation, patients' marital and socioeconomic status and choice of treatment]. Ugeskr Laeger (1979) 0.75
[Occurrence of peptic ulcer in relation to matrimonal status]. Ugeskr Laeger (1979) 0.75
Zidovudine treatment of AIDS and ARC in Denmark 1987. Scand J Infect Dis (1989) 0.75
[Bisacodyl (Toilax) and oral mannitol as a cathartic in the preparation for radiographic examination of the colon]. Ugeskr Laeger (1983) 0.75
[Principles of medical statistics. XI. Comparisons between survival curves]. Nord Med (1971) 0.75
[Mortality in peptic ulcer]. Ugeskr Laeger (1978) 0.75
Seasonal periodicity of peptic ulcer disease. A prospective radiologic study. Scand J Gastroenterol (1985) 0.75
[Prognosis in hemorrhagic proctitis]. Ugeskr Laeger (1978) 0.75
[Prognostic value of the extended histamine test in gastric ulcer]. Nord Med (1971) 0.75
A comparative study of the influence of tolfenamic acid (Clotam) and diclofenac sodium (Voltaren) on the gastrointestinal mucosa in patients with a history of NSAID-related dyspeptic symptoms. Pharmacol Toxicol (1994) 0.75
[A descriptive epidemiological study of peptic ulcer in Copenhagen County]. Ugeskr Laeger (1975) 0.75
[Radiological examination of the stomach in Copenhagen country. Incidence and results]. Ugeskr Laeger (1976) 0.75
[Psychological problems in patients with upper abdominal pain]. Ugeskr Laeger (1976) 0.75
[Treatment of duodenal ulcer with a new bicyclic compound: prindamin. A double-blind controlled trial]. Ugeskr Laeger (1977) 0.75
[An epidemiological study of ulcerative colitis in Copenhagen County]. Nord Med (1968) 0.75
[Ulcerative colitis in children. Treatment, course and prognosis]. Ugeskr Laeger (1972) 0.75
[Exchange of paraclinical information between the primary and secondary health sectors]. Ugeskr Laeger (2001) 0.75
Developments in the treatment of peptic ulcer. Scand J Gastroenterol Suppl (1987) 0.75
[Causes of death in duodenal and gastric ulcer]. Ugeskr Laeger (1977) 0.75
[The prophylactic effect of salazosulfapyridine in ulcerative colitis after a period of one year without symptoms on long-term treatment. A double-blind investigation]. Ugeskr Laeger (1972) 0.75
[Babesia choloepi n. sp. (Apicomplexa, Piroplasmida), a parasite of the two-toed sloth, Choloepus didactylus (Linnaeus, 1758) (Xenarthra, Bradypodidae), in French Guiana]. Ann Parasitol Hum Comp (1988) 0.75
[Prostaglandin E1 (misoprostol) versus cimetidine in the treatment of duodenal ulcer. A controlled clinical trial]. Ugeskr Laeger (1987) 0.75
[A nosographic study of x-ray negative dyspepsia]. Ugeskr Laeger (1976) 0.75
[Effect of elemental diet on chronic abdominal pain occurring after abdominal surgery. A controlled clinical study]. Ugeskr Laeger (1979) 0.75
[Extended Danish classification of liver- and bile duct diseases (the DASL-code)]. Ugeskr Laeger (1980) 0.75
[Tobacco and alcohol are risk factors of complicated peptic ulcers. A prospective cohort study]. Ugeskr Laeger (2001) 0.75
Prevention of duodenal ulcer recurrence with penicillin. A double-blind, placebo-controlled trial. Scand J Gastroenterol (1993) 0.75
[Survival models in clinical research]. Ugeskr Laeger (1971) 0.75
[Abdominal angina caused by intimal fibroplasia in the mesenteric vessels]. Ugeskr Laeger (1988) 0.75
[The long-term prognosis of duodenal ulcer. A follow-up study and questionnaires concerning practitioners' prognostic expectations]. Ugeskr Laeger (1979) 0.75
[The relationship of Helicobacter pylori to iron status--serum ferritin and hemoglobin. A seroepidemiologic survey of 2794 Danes]. Ugeskr Laeger (2000) 0.75
Epidemiology in gastroenterology. Scand J Gastroenterol Suppl (1996) 0.75
[Helicobacter pylori infection and socioeconomic factors among adult Danes]. Ugeskr Laeger (1998) 0.75
A double-blind trial of the symptomatic effect of prindamine in duodenal ulcer patients. Scand J Gastroenterol Suppl (1976) 0.75
[Photorectoscopy]. Ugeskr Laeger (1969) 0.75
[Surgical treatment of peptic ulcer. An epidemiologic study of the incidence of surgery in a geographically defined ulcer population]. Ugeskr Laeger (1979) 0.75
Vagal tone on the pancreatic polypeptide cell in duodenal ulcer patients. Correction for maximal and minimal secretory capacity. Scand J Gastroenterol (1985) 0.75